IL-33-responsive Lineage- CD25+ CD44(hi) Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs

Overview

Journal J Immunol

Specialty Allergy & Immunology

Date 2011 Dec 27

PMID 22198948

Citations 290

Authors

Kathleen R Bartemes

Koji Iijima

Takao Kobayashi

Gail M Kephart

Andrew N Mckenzie

Hirohito Kita

Affiliations

Soon will be listed here.

Abstract

Innate immunity provides the first line of response to invading pathogens and a variety of environmental insults. Recent studies identified novel subsets of innate lymphoid cells that are capable of mediating immune responses in mucosal organs. In this paper, we describe a subset of lymphoid cells that is involved in innate type 2 immunity in the lungs. Airway exposure of naive BALB/c or C57BL/6J mice to IL-33 results in a rapid (<12 h) production of IL-5 and IL-13 and marked airway eosinophilia independently of adaptive immunity. In the lungs of nonsensitized naive mice, IL-33-responsive cells were identified that have a lymphoid morphology, lack lineage markers, highly express CD25, CD44, Thy1.2, ICOS, Sca-1, and IL-7Rα (i.e., Lin(-)CD25(+)CD44(hi) lymphoid cells), and require IL-7Rα for their development. Airway exposure of naive mice to a clinically relevant ubiquitous fungal allergen, Alternaria alternata, increases bronchoalveolar lavage levels of IL-33, followed by IL-5 and IL-13 production and airway eosinophilia without T or B cells. This innate type 2 response to the allergen is nearly abolished in mice deficient in IL-33R (i.e., ST2), and the Lin(-)CD25(+)CD44(hi) lymphoid cells in the lungs are required and sufficient to mediate the response. Thus, a subset of innate immune cells that responds to IL-33 and vigorously produces Th2-type cytokines is present in mouse lungs. These cells may provide a novel mechanism for type 2 immunity in the airways and induction of allergic airway diseases such as asthma.

Citing Articles

Chronic Inflammation in Asthma: Looking Beyond the Th2 Cell.

Olsthoorn S, van Krimpen A, Hendriks R, Stadhouders R Immunol Rev. 2025; 330(1):e70010.

PMID: 40016948 PMC: 11868696. DOI: 10.1111/imr.70010.

Ion Channels in the Immune Response of Asthma.

Yan L, Zhang L, Ogunniyi K, Hong L J Respir Biol Transl Med. 2024; 1(4).

PMID: 39664985 PMC: 11633837. DOI: 10.70322/jrbtm.2024.10019.

Group 2 Innate Lymphoid Cells in Allergic Rhinitis.

Wang S, Liu X, Lin X, Lv X, Zhang H J Inflamm Res. 2024; 17:8599-8610.

PMID: 39539728 PMC: 11559184. DOI: 10.2147/JIR.S485128.

PIP-seq identifies novel heterogeneous lung innate lymphocyte population activation after combustion product exposure.

Huang Y, Wang X, Kim J, Yao X, Sethi A, Strohm A Sci Rep. 2024; 14(1):20167.

PMID: 39215111 PMC: 11364781. DOI: 10.1038/s41598-024-70880-y.

Adjuvant-independent airway sensitization and infection mouse models leading to allergic asthma.

Radhouani M, Starkl P Front Allergy. 2024; 5:1423938.

PMID: 39157265 PMC: 11327155. DOI: 10.3389/falgy.2024.1423938.

References

Baekkevold E, Roussigne M, Yamanaka T, Johansen F, Jahnsen F, Amalric F . Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol. 2003; 163(1):69-79. PMC: 1868188. DOI: 10.1016/S0002-9440(10)63631-0. View

Kurowska-Stolarska M, Kewin P, Murphy G, Russo R, Stolarski B, Garcia C . IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol. 2008; 181(7):4780-90. DOI: 10.4049/jimmunol.181.7.4780. View

Voehringer D, Shinkai K, Locksley R . Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity. 2004; 20(3):267-77. DOI: 10.1016/s1074-7613(04)00026-3. View

Barrett N, Austen K . Innate cells and T helper 2 cell immunity in airway inflammation. Immunity. 2009; 31(3):425-37. PMC: 3353417. DOI: 10.1016/j.immuni.2009.08.014. View

Gudbjartsson D, Bjornsdottir U, Halapi E, Helgadottir A, Sulem P, Jonsdottir G . Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet. 2009; 41(3):342-7. DOI: 10.1038/ng.323. View

Cherry W, Yoon J, Bartemes K, Iijima K, Kita H . A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol. 2008; 121(6):1484-90. PMC: 2821937. DOI: 10.1016/j.jaci.2008.04.005. View

Xu D, Chan W, Leung B, Huang F, Wheeler R, Piedrafita D . Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med. 1998; 187(5):787-94. PMC: 2212173. DOI: 10.1084/jem.187.5.787. View

Rank M, Kobayashi T, Kozaki H, Bartemes K, Squillace D, Kita H . IL-33-activated dendritic cells induce an atypical TH2-type response. J Allergy Clin Immunol. 2009; 123(5):1047-54. PMC: 2711963. DOI: 10.1016/j.jaci.2009.02.026. View

Sugamura K, Asao H, Kondo M, Tanaka N, Ishii N, Nakamura M . The common gamma-chain for multiple cytokine receptors. Adv Immunol. 1995; 59:225-77. DOI: 10.1016/s0065-2776(08)60632-x. View

10.

Perrigoue J, Saenz S, Siracusa M, Allenspach E, Taylor B, Giacomin P . MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat Immunol. 2009; 10(7):697-705. PMC: 2711559. DOI: 10.1038/ni.1740. View

11.

Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan T . IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005; 23(5):479-90. DOI: 10.1016/j.immuni.2005.09.015. View

12.

Robinson D, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley A . Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 1992; 326(5):298-304. DOI: 10.1056/NEJM199201303260504. View

13.

Chang Y, Kim H, Albacker L, Baumgarth N, McKenzie A, Smith D . Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol. 2011; 12(7):631-8. PMC: 3417123. DOI: 10.1038/ni.2045. View

14.

Neill D, Wong S, Bellosi A, Flynn R, Daly M, Langford T . Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010; 464(7293):1367-70. PMC: 2862165. DOI: 10.1038/nature08900. View

15.

Smithgall M, Comeau M, Yoon B, Kaufman D, Armitage R, Smith D . IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol. 2008; 20(8):1019-30. DOI: 10.1093/intimm/dxn060. View

16.

Guo L, Wei G, Zhu J, Liao W, Leonard W, Zhao K . IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci U S A. 2009; 106(32):13463-8. PMC: 2726336. DOI: 10.1073/pnas.0906988106. View

17.

Buonocore S, Ahern P, Uhlig H, Ivanov I, Littman D, Maloy K . Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature. 2010; 464(7293):1371-5. PMC: 3796764. DOI: 10.1038/nature08949. View

18.

Spits H, Di Santo J . The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol. 2010; 12(1):21-7. DOI: 10.1038/ni.1962. View

19.

Kouzaki H, Iijima K, Kobayashi T, OGrady S, Kita H . The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J Immunol. 2011; 186(7):4375-87. PMC: 3062674. DOI: 10.4049/jimmunol.1003020. View

20.

Louten J, Rankin A, Li Y, Murphy E, Beaumont M, Moon C . Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation. Int Immunol. 2011; 23(5):307-15. DOI: 10.1093/intimm/dxr006. View